Sanofi
SNY
$52.76
$0.440.84%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -11.78% | -13.22% | -10.23% | |
| Total Other Revenue | -- | 30.18% | 30.52% | 37.26% | |
| Total Revenue | -- | -9.36% | -10.71% | -7.74% | |
| Cost of Revenue | -- | -6.72% | -6.79% | -5.80% | |
| Gross Profit | -- | -10.50% | -12.39% | -8.57% | |
| SG&A Expenses | -- | -18.29% | -18.19% | -12.73% | |
| Depreciation & Amortization | -- | -12.45% | -5.66% | -4.81% | |
| Other Operating Expenses | -- | 105.90% | 90.45% | 129.70% | |
| Total Operating Expenses | -- | -2.16% | -2.97% | -0.38% | |
| Operating Income | -- | -34.63% | -36.92% | -31.61% | |
| Income Before Tax | -- | -58.38% | -53.73% | -40.39% | |
| Income Tax Expenses | -- | -68.35% | -67.83% | -47.76% | |
| Earnings from Continuing Operations | -- | -55.83% | -50.20% | -38.66% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | 67.68% | 69.70% | 67.39% | |
| Net Income | -- | -49.75% | -43.75% | -34.13% | |
| EBIT | -- | -34.63% | -36.92% | -31.61% | |
| EBITDA | -- | -26.29% | -27.56% | -23.24% | |
| EPS Basic | -- | -49.76% | -43.75% | -34.12% | |
| Normalized Basic EPS | -- | -49.70% | -55.37% | -55.37% | |
| EPS Diluted | -- | -49.84% | -43.82% | -34.18% | |
| Normalized Diluted EPS | -- | -50.05% | -55.37% | -55.37% | |
| Average Basic Shares Outstanding | -- | -0.07% | -0.07% | -0.05% | |
| Average Diluted Shares Outstanding | -- | 0.20% | 0.03% | 0.04% | |
| Dividend Per Share | -- | 11.29% | 11.29% | 11.29% | |
| Payout Ratio | -- | -- | -- | -- | |